Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubna Q Khasawneh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2022
Mendelian randomization in pharmacogenomics: The unforeseen potentialsLubna Q Khasawneh, Zeina N Al-Mahayri, Bassam R Ali
Metabolic Syndrome and Related Disorders|March 28, 2017
High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic SyndromeMohammad J Alkhatatbeh, Khalid K Abdul-Razzak, Lubna Q Khasawneh, et al.
Biomedical Reports|June 16, 2018
Prevalence of musculoskeletal pain in association with serum 25-hydroxyvitamin D concentrations in patients with type 2 diabetes mellitusMohammad J Alkhatatbeh, Khalid K Abdul-Razzak, Lubna Q Khasawneh, et al.
Human Genomics|January 4, 2024
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati populationLubna Q Khasawneh, Habiba Alsafar, Hiba Alblooshi, et al.
Frontiers in Pharmacology|October 13, 2025
Pharmacogenomic biomarkers of ACE inhibitor-induced cough in a multi-ethnic UAE cohortSahar M Altoum, Zeina N Al-Mahayri, Lubna Q Khasawneh, et al.
Iscience|March 27, 2026
Pharmacogenomic diversity among Arab populations: A systematic reviewZeina N Al-Mahayri, Mais N Alqasrawi, Lubna Q Khasawneh, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 5, 2023
An assessment of the current practice of community pharmacists for the disposal of medication waste in the United Arab Emirates: A deep analysis at a glanceZelal Kharaba, Lubna Q Khasawneh, Lynn Aloum, et al.
Human Genomics|September 26, 2022
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab EmiratesZeina N Al-Mahayri, Lubna Q Khasawneh, Mais N Alqasrawi, et al.
Clinical Pharmacology and Therapeutics|August 13, 2024
PharmVar GeneFocus: CYP4F2Pablo Zubiaur, Cristina Rodríguez-Antona, Erin C Boone, et al.
Human Genomics|April 25, 2025
Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE's multiethnic populationMais N Alqasrawi, Zeina N Al-Mahayri, Areej S AlBawa'neh, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2022
Mendelian randomization in pharmacogenomics: The unforeseen potentialsLubna Q Khasawneh, Zeina N Al-Mahayri, Bassam R Ali
Metabolic Syndrome and Related Disorders|March 28, 2017
High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic SyndromeMohammad J Alkhatatbeh, Khalid K Abdul-Razzak, Lubna Q Khasawneh, et al.
Biomedical Reports|June 16, 2018
Prevalence of musculoskeletal pain in association with serum 25-hydroxyvitamin D concentrations in patients with type 2 diabetes mellitusMohammad J Alkhatatbeh, Khalid K Abdul-Razzak, Lubna Q Khasawneh, et al.
Human Genomics|January 4, 2024
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati populationLubna Q Khasawneh, Habiba Alsafar, Hiba Alblooshi, et al.
Frontiers in Pharmacology|October 13, 2025
Pharmacogenomic biomarkers of ACE inhibitor-induced cough in a multi-ethnic UAE cohortSahar M Altoum, Zeina N Al-Mahayri, Lubna Q Khasawneh, et al.
Iscience|March 27, 2026
Pharmacogenomic diversity among Arab populations: A systematic reviewZeina N Al-Mahayri, Mais N Alqasrawi, Lubna Q Khasawneh, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 5, 2023
An assessment of the current practice of community pharmacists for the disposal of medication waste in the United Arab Emirates: A deep analysis at a glanceZelal Kharaba, Lubna Q Khasawneh, Lynn Aloum, et al.
Human Genomics|September 26, 2022
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab EmiratesZeina N Al-Mahayri, Lubna Q Khasawneh, Mais N Alqasrawi, et al.
Clinical Pharmacology and Therapeutics|August 13, 2024
PharmVar GeneFocus: CYP4F2Pablo Zubiaur, Cristina Rodríguez-Antona, Erin C Boone, et al.
Human Genomics|April 25, 2025
Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE's multiethnic populationMais N Alqasrawi, Zeina N Al-Mahayri, Areej S AlBawa'neh, et al.
Pageof 2